Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
8°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Taro Pharm Inds
(NY:
TARO
)
42.97
UNCHANGED
Last Price
Updated: 7:00 PM EDT, Jun 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Taro Pharm Inds
< Previous
1
2
Next >
TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
September 24, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
CORRECTING and REPLACING TARO Investors Have Opportunity to Lead Taro Pharmaceutical Industries Ltd. Securities Fraud Lawsuit with the Schall Law Firm
September 16, 2024
From
The Schall Law Firm
Via
Business Wire
TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
September 16, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Taro Provides Results for Year Ended March 31, 2024
May 20, 2024
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Taro to Release Full Year Results on May 20, 2024
May 15, 2024
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger
May 08, 2024
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO
April 22, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
April 15, 2024
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO
February 06, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rover Group, Inc. (Nasdaq - ROVR), M.D.C. Holdings, Inc. (NYSE - MDC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE - PGTI)
January 26, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
Taro Provides Results for December 31, 2023
January 25, 2024
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rover Group, Inc. (Nasdaq - ROVR), M.D.C. Holdings, Inc. (NYSE - MDC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE - PGTI)
January 22, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
Taro to Release Third Quarter Results on January 25, 2024
January 19, 2024
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: M.D.C. Holdings, Inc. (NYSE - MDC), Cornerstone Financial Corporation (OTC - CFIC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE -
January 18, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
TARO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Taro Pharmaceutical Industries Ltd. Is Fair to Shareholders
January 17, 2024
From
Halper Sadeh LLC
Via
Business Wire
Taro Provides Results for September 30, 2023
October 26, 2023
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Taro to Release Second Quarter Results on October 26, 2023
October 19, 2023
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Taro Provides Results for the Quarter Ended June 30, 2023
July 26, 2023
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Taro to Release First Quarter Results on July 26, 2023
July 19, 2023
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2023
June 30, 2023
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) Near the Top of Equities by Percentage Gain on 5/30
May 30, 2023
Via
Investor Brand Network
Taro Provides Results for Year Ended March 31, 2023
May 23, 2023
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Taro to Release Full Year Results on May 23, 2023
May 18, 2023
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Taro Provides Results for December 31, 2022
January 24, 2023
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Taro to Release Third Quarter Results on January 24, 2023
January 19, 2023
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Taro Provides Results for September 30, 2022
October 27, 2022
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Taro to Release Second Quarter Results on October 27, 2022
October 24, 2022
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Taro Provides Results for the Quarter Ended June 30, 2022
July 27, 2022
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2022
July 26, 2022
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Taro to Release First Quarter Results on July 27, 2022
July 26, 2022
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
